He’ll hold a 60% stake in More Life and Canopy Growth will own the remaining 40%.
Firm’s pharmaceutical business, Spectrum Therapeutics, has made strides in the UK and Luxembourg.
Mike Cammalleri’s BioSteel is now developing a line of cannabidiol products.
C3 Cannabinoid Compound Co. has two manufacturing facilities specializing in natural extraction and synthetic cannabinoid production.
The Ontario-based company has announced plans to invest between US$100 million and US$150 million at its proposed New York hemp operations.
Canopy Growth says it will use Stewart’s knowledge of consumer products.
Canopy Growth embarking on a Health Canada-approved clinical trial using cannabis-based products to treat animal anxiety.